These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23720171)

  • 21. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of diabetes mellitus--yes].
    Schwarz P
    Dtsch Med Wochenschr; 2014 Mar; 139(10):490. PubMed ID: 24570196
    [No Abstract]   [Full Text] [Related]  

  • 23. Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test?
    Wong VW; Chan HL
    J Gastroenterol Hepatol; 2011 Mar; 26(3):419-20. PubMed ID: 21332536
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up.
    Perseghin G; Calori G; Lattuada G; Ragogna F; Dugnani E; Garancini MP; Crosignani P; Villa M; Bosi E; Ruotolo G; Piemonti L
    Acta Diabetol; 2012 Dec; 49(6):421-8. PubMed ID: 22215126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diabetes, insulin, insulin analogues, and cancer].
    Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
    Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease.
    Sardu C; De Lucia C; Wallner M; Santulli G
    J Diabetes Res; 2019; 2019():1905194. PubMed ID: 31236416
    [No Abstract]   [Full Text] [Related]  

  • 27. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up.
    Calori G; Lattuada G; Ragogna F; Garancini MP; Crosignani P; Villa M; Bosi E; Ruotolo G; Piemonti L; Perseghin G
    Hepatology; 2011 Jul; 54(1):145-52. PubMed ID: 21488080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tipping the balance: the pathophysiology of obesity and type 2 diabetes mellitus.
    McKenney RL; Short DK
    Surg Clin North Am; 2011 Dec; 91(6):1139-48, vii. PubMed ID: 22054144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation and management of childhood type 2 diabetes mellitus.
    Scollan-Koliopoulos M; David B
    Prim Care Diabetes; 2011 Oct; 5(3):151-8. PubMed ID: 21616738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Insulin resistance].
    Waldhäusl W
    Acta Med Austriaca; 1992; 19(4):96-100. PubMed ID: 1290322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty liver: a novel component of the metabolic syndrome.
    Kotronen A; Yki-Järvinen H
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance.
    Raffaella C; Francesca B; Italia F; Marina P; Giovanna L; Susanna I
    Obesity (Silver Spring); 2008 May; 16(5):958-64. PubMed ID: 18277391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topics in type 2 diabetes and insulin resistance.
    Bloomgarden ZT
    Diabetes Care; 2009 Feb; 32(2):e13-9. PubMed ID: 19171729
    [No Abstract]   [Full Text] [Related]  

  • 36. What advice should be given to patients with NAFLD about the consumption of alcohol?
    Sozio MS; Chalasani N; Liangpunsakul S
    Nat Clin Pract Gastroenterol Hepatol; 2009 Jan; 6(1):18-9. PubMed ID: 19015652
    [No Abstract]   [Full Text] [Related]  

  • 37. Artificially sweetened taste of insulin resistance?
    Shearer J; Nettleton J
    Appl Physiol Nutr Metab; 2016 Jul; 41(7):iii. PubMed ID: 27383430
    [No Abstract]   [Full Text] [Related]  

  • 38. The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease.
    Bell DS
    South Med J; 2009 Oct; 102(10):991-2. PubMed ID: 19738529
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause.
    Taylor R
    Diabetologia; 2008 Oct; 51(10):1781-9. PubMed ID: 18726585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstructive sleep apnea and dyslipidemia: importance of the liver axis.
    Mirrakhimov AE; Mirrakhimov EM
    Sleep Breath; 2013 May; 17(2):443-4. PubMed ID: 23070526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.